Plus Therapeutics receives Nasdaq delisting notice for bid price below $1.00

PLUS THERAPEUTICS, INC.

Nasdaq notified Plus Therapeutics on May 16, 2025 of non-compliance with minimum bid price rule (closing bid < $1.00 for 30 consecutive days).
Initial compliance period ends November 12, 2025; must close at $1.00+ for 10 consecutive business days.
If not cured by Nov 12, may be eligible for additional 180-day period if meets other listing standards.
Company will consider options including reverse stock split to regain compliance; no assurance of success.
Potential delisting can be appealed; common stock continues trading on Nasdaq during process.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.